Skip to main content
Female doctor

GORE® VIABAHN® Device family

Join the next generation of care in the treatment of aortoiliac occlusive disease

Aortoiliac bifurcation (kissing stent technique) lesions

Common challenges:

  • Plaque shift
  • Embolization concerns
  • Flow dynamics
  • Tapered anatomy
  • Rupture risk

The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) delivers:

Case examples

Freedom from target lesion revascularization (fTLR) in kissing stents (N = 118)

fTLR Kissing graphic

 

 

† Data on file 2020; W. L. Gore & Associates, Inc; Flagstaff, AZ.


Moderate to severely calcified focal or diffuse lesions

Common challenges:

  • Sufficient radial strength
  • Embolization concerns
  • Need for reintervention
  • Rupture risk

The VBX Stent Graft delivers:

Case examples

fTLR in TASC II C and D lesions (N = 77)

TASC Graphic

 

 

† Data on file 2020; W. L. Gore & Associates, Inc; Flagstaff, AZ.


Focal or diffuse common iliac artery lesions

Common challenges:

  • Embolization concerns
  • Conformability
  • Need for reintervention (e.g., neointimal hyperplasia)
  • Rupture risk

The VBX Stent Graft delivers:

Case examples

    Independent stainless steel ring design for flexibility and conformability. Highly flexible stent and catheter facilitates deployment. ePTFE graft covers and excludes disease.

Focal or diffuse external iliac artery lesions

Common challenges:

  • Deployment accuracy
  • Tortuosity
  • Vessel movement
  • Embolization concerns

The GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface* delivers:

Case examples

  • Single wire nitinol frame for flexibility, trackability and fracture resistance.
  • CBAS Heparin Surface for lasting thromboresistance.1
  • ePTFE graft covers and excludes disease.

*As used by Gore, Heparin Bioactive Surface refers to Gore’s proprietary CBAS Heparin Surface.

† Data on file 2020; W. L. Gore & Associates, Inc; Flagstaff, AZ.

  1. CBAS Heparin Surface. W. L. Gore & Associates website. Accessed February 11,2021. https://www.goremedical.com/cbas/references